Akebia Therapeutics (AKBA) Misses Q4 EPS by 38c
Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.66), $0.38 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.
Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.66), $0.38 worse than the analyst estimate of ($0.28).
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.